Taro Pharmaceutical Industries (TARO) Revenue and Net Income History

Historical revenue, operating income and net income for Taro Pharmaceutical Industries (TARO) over the last 10 years. The current TTM revenue for Taro Pharmaceutical Industries as of January 12, 2018 is $0.88B.

Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.242B $0.879B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.